Preview

Problems of Endocrinology

Advanced search

A case of severe neonatal hyperparathyroidism due to defect in calcium receptors

https://doi.org/10.14341/probl201056427-33

Abstract

The first case of severe neonatal hyperparathyroidism in the Russian population verified by molecular-genetic testing is described. The patient presented with very high calcium and parathyroid hormone (PTH) levels and showed characteristic clinical symptoms of hyperparathyroidism in the absence of lesions in long tubular bones. Removal of all parathyroid glands resulted in normalization of laboratory parameters and general health status of the patient. Diagnosis of severe neonatal hyperparathyroidism was confirmed by sequencing the CASR gene while parents of the child were shown to suffer familial hypocalciuric hypercalcemia.

References

1. D'Souza-Li L., Yang B., Canaff L. et al. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia. J Clin Endocrinol Metab 2002; 87: 3: 1309-1318.

2. Hebert S.C. Extracellular calcium-sensing receptor: implications for calcium and magnesium handling in the kidney. Kidney. Int 1996; 50: 6: 2129-2139

3. Hauache O.M. Extracellular calcium-sensing receptor: structural and functional features and association with diseases. Braz J Med Biol Res 2001; 34: 5: 577-584.

4. Den Dunnen J.T., Antonarakis E. Nomenclature for the description of human sequence variations. Hum Genet 2001; 109: 121-124.

5. Ward B.K., Magno A.L., Davis E.A. et al. Functional Deletion of the Calcium-Sensing Receptor in a Case of Neonatal Severe Hyperparathyroidism. J Clin Endocrinol Metab 2004; 89: 8: 3721-3730.

6. Pearce S., Steinmann B. Casting new light on the clinical spectrum of neonatal severe hyperparathyroidism. Clin Endocrinol (Oxf) 1999; 50: 691-693.

7. Garrett J.E., Capuano I.V., Hammerland L.G. et al. Molecular cloning and functional expression of human parathyroid calcium receptor cDNA. J Biol Chem 1995; 270: 12919-12925.

8. Руководство по детской эндокринологии. Под ред И.И. Дедова, В.А. Петерковой. М: Универсум паблишинг 2006; 600.

9. МакДермотт М.Т. Секреты эндокринологии. Пер. с англ. М: БИНОМ 1998; 416.

10. Marx S.J., Fraser D., Rapoport A. Familial hypocalciuric hypercalcemia: mild expression of the gene in heterozygotes and severe expression in homozygotes. Am J Med 1985; 78: 1: 15-22.

11. Aida K., Koishi S., Inoue M. et al. Familial hypocalciuric hypercalcemia associated with mutation in the human Ca2+-sensing receptor gene. J Clin Endocrinol Metab 1995; 80: 9: 2594-2598.

12. Harris S.S., D'Ercole A.J. Neonatal hyperparathyroidism: the natural course in the absence of surgical intervention. Pediatrics 1989; 83: 1: 53-56.

13. Bai M., Pearce S.H., Kifor O. et al. In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J Clin Invest 1997; 99: 1: 88-96.

14. Marx S.J., Attie M.F., Levine M.A. et al. The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine 1981; 60: 6: 397-412.

15. Brown E.M., MacLeod R.J. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 2001; 81: 239-297.

16. Law W.M. Jr., Heath H.D. Familial benign hypercalcemia (hypocalciuric hypercalcemia): clinical and pathogenetic studies in 21 families. Ann Intern Med 1985; 102: 4: 511-519.

17. Pollak M.R., Chou Y.H., Marx S.J. et al. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism: effect of mutant gene dosage on phenotype. J Clin Invest 1994; 93: 3: 1108-1112.

18. Kobayashi M., Tanaka H., Tsuzuki K. et al. Two novel missense mutations in calcium-sensing receptor gene associated with neonatal severe hyperparathyroidism. J Clin Endocrinol Metab 1997; 82: 8: 2716-2719.

19. Carling T., Szabo E., Bai M. et al. Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab 2000; 85: 5: 2042-2047.

20. Pidasheva S., D'Souza-Li L., Canaff L. et al. CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 2004; 24: 2: 107-111.

21. Pollak M.R., Brown E.M., Chou Y.H. et al. Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993; 75: 7: 1297-1303.

22. Silve C., Petrel C., Leroy C. et al. Delineating a Ca2+ binding pocket within the venus flytrap module of the human calcium-sensing receptor. J Biol Chem 2005; 280: 45: 37917-37923.

23. Hendy G.N., D'Souza-Li L., Yang B. et al. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 2000; 16: 4: 281-296.

24. Hu J., McLarnon S.J., Mora S. et al. A region in the seven-transmembrane domain of the human Ca2+ receptor critical for response to Ca2+. J Biol Chem 2005; 280: 6: 5113-5120.


Review

For citations:


Vitebskaia A.V., Petriaĭkina E.E., Razumovskiĭ A.I., Pavlov A.A., Tiul'pakov A.N. A case of severe neonatal hyperparathyroidism due to defect in calcium receptors. Problems of Endocrinology. 2010;56(4):27-33. https://doi.org/10.14341/probl201056427-33

Views: 534


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)